Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Zimmer Holdings, Inc. : Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/02/2013 | 02:05pm CEST

LONDON, April 2, 2013 /PRNewswire/ --

Medical appliances & equipment makers have been critical of President Obama's Affordable Care Act (ACA). Under the healthcare reform, medical appliances & equipment makers such as Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Medtronic Inc. (NYSE: MDT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM) are required to pay a 2.3% excise tax on U.S. sales. The industry has been lobbying to repeal the 2.3% tax on U.S. sales, saying that it would lead to higher costs and hamper research and development activities. Medical appliances & equipment makers ended mostly lower on Monday, tracking losses in the broad market. StockCall has posted free technical research reports on BSX, ABT, MDT, ZMH, and ETRM and these can be accessed by signing up at

http://www.stockcall.com/analysis

Shares of Boston Scientific Corporation touched a 52-week high of $7.86 yesterday, however, the stock failed to hold on to its gains. It closed 0.13% lower at $7.80 on above average volume of 29.66 million. Boston Scientific shares have gained more than 4.80% in the last three trading sessions. The stock has outperformed the broad market so far in 2013, gaining more than 36%. Its MACD has just crossed above the signal line, which is a strong bullish signal. Download the free report on BSX upon registration at

http://www.StockCall.com/BSX040213.pdf

Abbott Laboratories shares ended nearly flat in Monday's trading session. The stock fell to an intra-day low of $34.95 before paring most of its losses to finish the day 0.03% lower at $35.31 on volume of 6.03 million. The stock has gained nearly 2.80% in the last three sessions. Abbott's shares recently broke through $35 resistance level, which is a strong bullish signal. The positive trend is further confirmed by the stock's MACD chart. The company's shares are also trading above their 50-day and 200-day moving averages. ABT technical report can be accessed for free by signing up at

http://www.StockCall.com/ABT040213.pdf

Medtronic Inc.'s shares edged lower on Monday; however, the losses were limited. The stock closed 0.34% lower at $46.80 on volume of 2.81 million. The company's shares are currently trading close to their 52-week high of $47.40. The stock has outperformed the broad market in 2013, gaining more than 14%. Its shares are currently facing resistance at around $47. The stock's MACD is currently trading above the signal line and the zero-line, which is a bullish signal. The free report on MDT can be downloaded by signing up now at

http://www.StockCall.com/MDT040213.pdf

Zimmer Holdings Inc.'s shares ended marginally lower yesterday. The stock ended the day 0.12% lower at $75.13 on volume of 693,613. Its shares are currently hovering around their 52-week high of $76.75. The stock saw a series of highs last week, which is a bullish signal. The upbeat trend is further confirmed by recent volume activity and the stock's MACD chart. Free report on ZMH can be accessed by registering at

http://www.StockCall.com/ZMH040213.pdf

EnteroMedics Inc.'s shares rose sharply on Monday even as the broad market struggled. The stock closed 1% higher at $1.01 on volume of 776,418. EnteroMedics' shares touched an intra-day high of $1.04 yesterday. Despite the gains, the stock is down nearly 1% in the last three trading sessions. Shares of ETRM are currently trading well below their 50-day and 200-day moving averages. Register with StockCall and download the research on ETRM for free at

http://www.StockCall.com/ETRM040213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ZIMMER BIOMET HOLDINGS INC
10/23 Smith & Nephew to buy Rotation Medical for up to $210 million
10/13 ZIMMER BIOMET : Daily Technical Summary Reports on Medical Equipment Stocks -- I..
10/12 ZIMMER BIOMET : Announces Audio Webcast and Conference Call of Third Quarter 201..
10/10 ZIMMER BIOMET : Announces Audio Webcast and Conference Call of Third Quarter 201..
10/06 ZIMMER BIOMET : Provides Update on Manufacturing Facilities in Guaynabo and Ponc..
10/04 ZIMMER BIOMET : Provides Update on Manufacturing Facilities in Guaynabo and Ponc..
10/04 ZIMMER BIOMET : Announces U.S. Launch of Avenue T TLIF Cage with Integrated Vert..
10/02 ZIMMER BIOMET : Announces U.S. Launch of Avenue® T TLIF Cage with Integrated Ver..
09/28 ZIMMER BIOMET HOLDINGS, INC. (NYSE : ZBH) Files An 8-K Entry into a Material Def..
09/28 ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creat..
More news
News from SeekingAlpha
10/12 Wright Can't Get It Right
10/09 First meeting of new FDA advisory committee this week
09/29 ZIMMER BIOMET : A Leading Medtech Player Facing Short-Term Issues
09/14 Dividend Champion, Contender And Challenger Stocks Going Ex-Div Next Week (Se..
09/01 ZIMMER BIOMET HOLDINGS : Undervalued And Unloved